Reiko Onishi

1.5k total citations · 1 hit paper
9 papers, 1.2k citations indexed

About

Reiko Onishi is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Reiko Onishi has authored 9 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Reiko Onishi's work include Psoriasis: Treatment and Pathogenesis (2 papers), T-cell and B-cell Immunology (2 papers) and Immune Cell Function and Interaction (2 papers). Reiko Onishi is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (2 papers), T-cell and B-cell Immunology (2 papers) and Immune Cell Function and Interaction (2 papers). Reiko Onishi collaborates with scholars based in Japan, United States and Malaysia. Reiko Onishi's co-authors include Sarah L. Gaffen, Michael Walter, Javier Rangel‐Moreno, John F. Alcorn, Derek Pociask, Troy D. Randall, Sang Mi Park, Lokesh Guglani, Jay K. Kolls and Michelle N. Messmer and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Reiko Onishi

9 papers receiving 1.2k citations

Hit Papers

Interleukin‐17 and its target genes: mechanisms of interl... 2010 2026 2015 2020 2010 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reiko Onishi Japan 6 774 225 189 180 142 9 1.2k
Aoi Akitsu Japan 9 882 1.1× 240 1.1× 115 0.6× 118 0.7× 155 1.1× 16 1.2k
Dominik Aschenbrenner United Kingdom 10 869 1.1× 428 1.9× 178 0.9× 169 0.9× 219 1.5× 14 1.4k
Christina E. Zielinski Germany 20 1.2k 1.6× 426 1.9× 237 1.3× 269 1.5× 226 1.6× 41 1.9k
Giovanni Almanzar Germany 20 638 0.8× 297 1.3× 391 2.1× 93 0.5× 167 1.2× 45 1.3k
Andrew Lucas Australia 21 636 0.8× 255 1.1× 193 1.0× 375 2.1× 170 1.2× 36 1.3k
Marina Tuzova United States 15 407 0.5× 219 1.0× 177 0.9× 82 0.5× 114 0.8× 17 953
Margot O’Toole United States 14 757 1.0× 178 0.8× 185 1.0× 149 0.8× 64 0.5× 28 1.2k
Wai Po Chong China 20 748 1.0× 249 1.1× 277 1.5× 161 0.9× 265 1.9× 35 1.3k
Afsaneh Soruri Germany 20 753 1.0× 355 1.6× 129 0.7× 195 1.1× 110 0.8× 28 1.3k
Matthew J. Lindemann United States 7 580 0.7× 162 0.7× 304 1.6× 146 0.8× 355 2.5× 9 1.1k

Countries citing papers authored by Reiko Onishi

Since Specialization
Citations

This map shows the geographic impact of Reiko Onishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reiko Onishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reiko Onishi more than expected).

Fields of papers citing papers by Reiko Onishi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reiko Onishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reiko Onishi. The network helps show where Reiko Onishi may publish in the future.

Co-authorship network of co-authors of Reiko Onishi

This figure shows the co-authorship network connecting the top 25 collaborators of Reiko Onishi. A scholar is included among the top collaborators of Reiko Onishi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reiko Onishi. Reiko Onishi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Sunami, Kazutaka, Shin‐ichi Fuchida, Kenshi Suzuki, et al.. (2022). Anti‐CD38 antibody isatuximab monotherapy for Japanese individuals with relapsed/refractory multiple myeloma: An update of the phase 1/2 ISLANDs study. Hematological Oncology. 41(3). 442–452. 1 indexed citations
2.
Sakudo, Akikazu, et al.. (2020). Inactivation of Non-Enveloped Viruses and Bacteria by an Electrically Charged Disinfectant Containing Meso-Structure Nanoparticles via Modification of the Genome. SHILAP Revista de lepidopterología. 2 indexed citations
3.
Hashimoto, Akiko, Yusuke Kawashima, Machie Sakuma, et al.. (2019). Inhibition of T cell activation and function by the adaptor protein CIN85. Science Signaling. 12(567). 15 indexed citations
5.
Takeuchi, Arata, Kosuke Miyauchi, Chitose Ishihara, et al.. (2015). CRTAM determines the CD4+ cytotoxic T lymphocyte lineage. The Journal of Experimental Medicine. 213(1). 123–138. 136 indexed citations
6.
Onishi, Reiko, et al.. (2010). SEF/IL-17R (SEFIR) Is Not Enough. Journal of Biological Chemistry. 285(43). 32751–32759. 43 indexed citations
7.
Onishi, Reiko & Sarah L. Gaffen. (2010). Interleukin‐17 and its target genes: mechanisms of interleukin‐17 function in disease. Immunology. 129(3). 311–321. 728 indexed citations breakdown →
8.
Lin, Yinyao, Alison Logar, Samantha Slight, et al.. (2009). Interleukin-17 Is Required for T Helper 1 Cell Immunity and Host Resistance to the Intracellular Pathogen Francisella tularensis. Immunity. 31(5). 799–810. 241 indexed citations
9.
Onishi, Reiko, et al.. (1987). Studies on a Viscous Substance of the Natto. Journal of home economics. 38(10). 871–876. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026